首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Regulatory issues for commercialization of tomatoes with an antisense polygalacturonase gene
Authors:Keith Redenbaugh  Ted Berner  Don Emlay  Bill Frankos  William Hiatt  Cathy Houck  Matt Kramer  Lori Malyj  Belinda Martineau  Nancy Rachman  Larisa Rudenko  Rick Sanders  Ray Sheehy  Roger Wixtrom
Institution:(1) Calgene, Inc., 1920 Fifth Street, 95616 Davis, California;(2) Environ, 4350 North Fairfax Drive, 22203 Arlington, Virginia
Abstract:Summary Significant progress has been made in development of transgenic plants containing agriculturally useful genes. Concurrent with scientific advances has been development of a regulatory infrastructure within the U.S. Department of Agriculture (USDA) for assessing safety of controlled release of genetically engineered plants into the environment, as well as creation of a food policy by the Food and Drug Administration (FDA). Field trials and safety assessments of tomato containing an antisense polygalacturonase gene (FLAVR SAVR™ tomato) have been conducted. A detailed safety analysis of thekan r selectable marker was also done. Based on these data plus nutritional measurements, lack of changes in levels of natural toxins, and lack of any unintended changes, we have requested that the USDA and FDA determine that this genetically engineered tomato is safe for release into the environment and human consumption. Presented in the Session-in-Depth “Field Test Requirements and Performance of Transgenic Plants” at the 1991 World Congress on Cell and Tissue Culture, Anaheim, California, June 16–20, 1991.
Keywords:tomato            Lycopersicon            antisense  polygalacturonase  USDA  FDA  safety assessment of transgenic plants
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号